Status:
UNKNOWN
Living With Long COVID: LONGCOVID-EXPERIENCE
Lead Sponsor:
Corporacion Parc Tauli
Collaborating Sponsors:
Universitat Autonoma de Barcelona
Conditions:
Long COVID
Experience, Life
Eligibility:
All Genders
18-65 years
Brief Summary
Background: One in ten people infected with COVID-19 presents persistent COVID, which consists of the presence of symptoms three months after the acute manifestations of COVID-19 and their persistence...
Eligibility Criteria
Inclusion
- women and men diagnosed with persistent COVID between March '20 to the present according to WHO criteria (persistent symptoms three months after the acute manifestations of COVID-19 and lasting at least two months and cannot be explained by an alternative diagnosis).
- treated at the Parc Taulí Hospital
- from 18 to 65 years
Exclusion
- people who do not understand or can communicate in Catalan or Spanish.
Key Trial Info
Start Date :
September 18 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2024
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT06118112
Start Date
September 18 2023
End Date
December 30 2024
Last Update
November 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Corporació Sanitària Parc Taulí
Sabadell, Barcelona, Spain, 08208